Latest News about DCPH
Recent news which mentions DCPH
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2021
February 10, 2021
From Benzinga
Deciphera Pharmaceuticals, Inc. (DCPH) Q4 2020 Earnings Call Transcript
February 09, 2021
Tickers
DCPH
From Motley Fool
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
February 09, 2021
From Benzinga
Earnings Scheduled For February 9, 2021
February 09, 2021
From Benzinga
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
February 06, 2021
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 3, 2020
December 03, 2020
From Benzinga
10 Biggest Price Target Changes For Thursday
November 12, 2020
From Benzinga
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
From Benzinga
The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference
September 13, 2020
From Benzinga
Tickers
DCPH
From Motley Fool
The Daily Biotech Pulse: Voyager, AbbVie End Collaboration, Thumbs Down For DBV's Peanut Allergy Patch, Tiziana Expedites COVID-19 Trial Plans
August 04, 2020
From Benzinga
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
August 02, 2020
From Benzinga
From Motley Fool
Deciphera Prepares To Collect Revenue After First FDA Approval: 'We Are Well-Positioned'
May 29, 2020
From Benzinga
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
May 29, 2020
From Benzinga
From Benzinga
From Motley Fool
Tickers
DCPH
From Motley Fool
10 Biggest Price Target Changes For Wednesday
May 06, 2020
From Benzinga
From Benzinga
From Benzinga
82 Biggest Movers From Yesterday
April 29, 2020
From Benzinga
56 Stocks Moving In Tuesday's Mid-Day Session
April 28, 2020
From Benzinga
Blueprint Medicines Tumbles 20.8% on Phase 3 Study Failure
April 28, 2020
From Motley Fool
From Benzinga
Here's Why Deciphera Pharmaceuticals Lost 22.7% in March
April 06, 2020
Tickers
DCPH
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.